1,423
Views
1
CrossRef citations to date
0
Altmetric
Articles

Bioimage analysis of cell physiology of primary lens epithelial cells from diabetic and non-diabetic cataract patients

, , , , , , , & show all
Pages 170-178 | Received 11 Nov 2020, Accepted 06 Dec 2020, Published online: 27 Dec 2020

References

  • Nemet AY, Vinker S, Levartovsky S, et al. Is cataract associated with cardiovascular morbidity? Eye (Lond)). 2010;24(8):1352–1358.
  • Pessoa R, Lira C, Nascimento MA, et al. Incidence of preoperative high blood pressure in cataract surgery among hypertensive and normotensive patients. Indian J Ophthalmol. 2010; 58(6):493–495.
  • Prokofyeva E, Wegener A, Zrenner E. Cataract prevalence and prevention in Europe: a literature review. Acta Ophthalmol. 2013;91(5):395–405.
  • Bron AJ, Sparrow J, Brown NAP, et al. The lens in diabetes. Eye. 1993;7(2):260–275.
  • Deepa K, Goud BM, Suma M, et al. Antioxidant and calcium levels in mature and immature diabetic cataract lens. Int J Life Sci. 2012; 6(1):56–60.
  • Nita M, Grzybowski A. The role of the reactive oxygen species and oxidative stress in the pathomechanism of the age-related ocular diseases and other pathologies of the anterior and posterior eye segments in adults. Oxid Med Cell Longev. 2016;2016:3164734–3164723.
  • Pollreisz A, Schmidt-Erfurth U. Diabetic cataract-pathogenesis, epidemiology and treatment. J Ophthalmol. 2010;2010:608751.
  • Sreelakshmi V, Abraham A. Age related or senile cataract: pathology, mechanism and management. Austin J Clin Ophthalmol. 2016;3(2):1067.
  • Ebihara Y, Kato S, Oshika T, et al. Posterior capsule opacification after cataract surgery in patients with diabetes mellitus. J Cataract Refract Surg. 2006; 32(7):1184–1187.
  • Nibourg LM, Gelens E, Kuijer R, et al. Prevention of posterior capsular opacification. Exp Eye Res. 2015;136:100–115.
  • Praveen MR, Vasavada AR, Shah GD, et al. A prospective evaluation of posterior capsule opacification in eyes with diabetes mellitus: a case–control study. Eye. 2014;28(6):720–727.
  • Apple DJ, Solomon KD, Tetz MR, et al. Posterior capsule opacification. Surv Ophthalmol. 1992; 37(2):73–116.(92)90073-3.
  • Pandey SK, Apple DJ, Werner L, et al. Posterior capsule opacification: a review of the aetiopathogenesis. Indian J Ophthalmol. 2004;52(2):99–112.
  • Sundelin K, Petersen A, Soltanpour Y, et al. In vitro growth of lens epithelial cells from cataract patients—association with possible risk factors for posterior capsule opacification. Open Ophthalmol J. 2014;8:19–23.
  • Hayashi K, Hayashi H, Nakao F, et al. Posterior capsule opacification after cataract surgery in patients with diabetes mellitus. Am J Ophthalmol. 2002;134(1):10–16.
  • Ionides A, Dowler JGF, Hykin PG, et al. Posterior capsule opacification following diabetic extracapsular cataract extraction. Eye. 1994;8(5):535–537.
  • Wu S, Tong N, Pan L, et al. Retrospective analyses of potential risk factors for posterior capsule opacification after cataract surgery. J Ophthalmol. 2018; 2018:1–7.
  • Elgohary MA, Dowler JG. Incidence and risk factors of Nd:YAG capsulotomy after phacoemulsification in non-diabetic and diabetic patients. Clin Exp Ophthalmol. 2006;0(0):060721075142001–060721075142034.
  • Zaczek A, Zetterström C. Posterior capsule opacification after phacoemulsification in patients with diabetes mellitus. J Cataract Refract Surg. 1999;25(2):233–237.
  • Islam Md. S., editor. Advances in experimental medicine and biology. Calcium signaling. Cham: Springer International Publishing; 2020. Vol. 1131.
  • Law B, Fowlkes V, Goldsmith JG, et al. Diabetes-induced alterations in the extracellular matrix and their impact on myocardial function. Microsc Microanal. 2012;18(1):22–34.
  • Trepat X, Chen Z, Jacobson K. Cell migration. In Terjung R, editor. Comprehensive physiology. Hoboken, NJ, USA: John Wiley & Sons, Inc.; 2012. p. c110012.
  • Huang Y, Kyriakides TR. The role of extracellular matrix in the pathophysiology of diabetic wounds. Matrix Biol Plus. 2020;6–7:100037.
  • Badaro E, Novais EA, Penha FM, et al. Vital dyes in ophthalmology: a chemical perspective. Curr Eye Res. 2014; 39(7):649–658.
  • Melendez RF, Kumar N, Maswadi SM, et al. Photodynamic actions of Indocyanine Green and Trypan Blue on human lens epithelial cells in vitro. Am J Ophthalmol. 2005;140(1):132–134.
  • Nanavaty MA, Johar K, Sivasankaran MA, et al. Effect of trypan blue staining on the density and viability of lens epithelial cells in white cataract. J Cataract Refract Surg. 2006;32(9):1483–1488.
  • Wierstra I, Alves J. FOXM1, a typical proliferation-associated transcription factor. Biol Chem. 2007;388(12):1257–1274. doi: 10.1515/BC.2007.159.PMID:18020943.
  • Simon H-U, Haj-Yehia A, Levi-Schaffer F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis. 2000;5(5):415–418.
  • Perše M. Oxidative stress in the pathogenesis of colorectal cancer: cause or consequence? Biomed Res Int. 2013;2013:725710–725719.
  • Schinke T, McKee MD, Karsenty G. Extracellular matrix calcification: where is the action? Nat Genet. 1999; 21(2):150–151.
  • Görlach A, Bertram K, Hudecova S, et al. Calcium and ROS: a mutual interplay. Redox Biol. 2015;6:260–271.
  • Sinumol S, Jayalakshmy PS, Sreedharan T, et al. Effect of intraoperative trypan blue on lens epithelial cells—histomorphological analysis. Saudi J Ophthalmol. 2019; 33(1):18–23.